|
Originally published In Press as doi:10.1074/jbc.M504008200 on June 27, 2005
J. Biol. Chem., Vol. 280, Issue 36, 31679-31685, September 9, 2005
Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action*
Christophe Graveleau ,
Vlad G. Zaha ,
Arash Mohajer ¶,
Ronadip R. Banerjee||,
Nicole Dudley-Rucker||,
Claire M. Steppan||**,
Michael W. Rajala ,
Philipp E. Scherer ,
Rexford S. Ahima||,
Mitchell A. Lazar||, and
E. Dale Abel, Established Investigator of the American Heart Association 
From the
Division of Endocrinology, Metabolism, and Diabetes and the Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, Utah 84112, the ||Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, and the  Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461
The adipocytokine resistin impairs glucose tolerance and insulin sensitivity in rodents. Here, we examined the effect of resistin on glucose uptake in isolated adult mouse cardiomyocytes. Murine resistin reduced insulin-stimulated glucose uptake, establishing the heart as a resistin target tissue. Notably, human resistin also impaired insulin action in mouse cardiomyocytes, providing the first evidence that human and mouse resistin homologs have similar functions. Resistin is a cysteinerich molecule that circulates as a multimer of a dimeric form dependent upon a single intermolecular disulfide bond, which, in the mouse, involves Cys26; mutation of this residue to alanine (C26A) produces a monomeric molecule that appears to be bioactive in the liver. Remarkably, unlike native resistin, monomeric C26A resistin had no effect on basal or insulin-stimulated glucose uptake in mouse cardiomyocytes. Resistin impairs glucose uptake in cardiomyocytes by mechanisms that involve altered vesicle trafficking. Thus, in cardiomyocytes, both mouse and human resistins directly impair glucose transport; and in contrast to effects on the liver, these actions of resistin require oligomerization.
Received for publication, April 13, 2005
* This work was supported in part by National Institutes of Health Grant DK58073 (to E. D. A.), Grants DK49210 and DK49780 (to M. A. L.), Medical Scientist Training Grant T32-GM07288 (to M. W. R.), and Grant DK55758 (to P. E. S.) and by research grants from the American Diabetes Association and the Ben and Iris Margolis Foundation (to E. D. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
¶ Supported by the Bioscience Undergraduate Research Program of the University of Utah.
** Present address: Pfizer Global Research and Development, Groton, CT 06340.
 To whom correspondence should be addressed: Div. of Endocrinology, Metabolism, and Diabetes and Program in Human Molecular Biology and Genetics, University of Utah School of Medicine, 15 North 2030 East, Bldg. 533, Rm. 3410B, Salt Lake City, UT 84112. Tel.: 801-585-0727; Fax: 801-585-0701; E-mail: dale.abel{at}hmbg.utah.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. B. Jorgensen, J. Honeyman, J. S. Oakhill, D. Fazakerley, J. Stockli, B. E. Kemp, and G. R. Steinberg
Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation
Am J Physiol Endocrinol Metab,
July 1, 2009;
297(1):
E57 - E66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Wright, J. Kim, J. Buchanan, S. Boudina, S. Sena, K. Bakirtzi, O. Ilkun, H. A. Theobald, R. C. Cooksey, K. V. Kandror, et al.
Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding
Cardiovasc Res,
May 1, 2009;
82(2):
351 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Princen, E. Bard, F. Sheikh, S. S. Zhang, J. Wang, W. M. Zago, D. Wu, R. D. Trelles, B. Bailly-Maitre, C. R. Kahn, et al.
Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature Death
Mol. Cell. Biol.,
January 15, 2009;
29(2):
378 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Palanivel, V. Vu, M. Park, X. Fang, and G. Sweeney
Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes
J. Endocrinol.,
December 1, 2008;
199(3):
389 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kao, P. Sassani, R. Azimov, A. Pushkin, N. Abuladze, J. Peti-Peterdi, W. Liu, D. Newman, and I. Kurtz
Oligomeric Structure and Minimal Functional Unit of the Electrogenic Sodium Bicarbonate Cotransporter NBCe1-A
J. Biol. Chem.,
September 26, 2008;
283(39):
26782 - 26794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cohen, D. Ilic, J. Raupachova, and W. H. Horl
Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes
J. Immunol.,
September 15, 2008;
181(6):
3761 - 3768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Karmazyn, D. M. Purdham, V. Rajapurohitam, and A. Zeidan
Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
Cardiovasc Res,
July 15, 2008;
79(2):
279 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, C. Jiang, G. Xu, N. Wang, Y. Zhu, C. Tang, and X. Wang
Homocysteine Upregulates Resistin Production From Adipocytes In Vivo and In Vitro
Diabetes,
April 1, 2008;
57(4):
817 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-W. Wang, H.-F. Hung, H. Chang, P. Kuan, and K.-G. Shyu
Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-{alpha}
Am J Physiol Heart Circ Physiol,
October 1, 2007;
293(4):
H2305 - H2312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Kusminski, N. F. da Silva, S. J. Creely, F. M. Fisher, A. L. Harte, A. R. Baker, S. Kumar, and P. G. McTernan
The in Vitro Effects of Resistin on the Innate Immune Signaling Pathway in Isolated Human Subcutaneous Adipocytes
J. Clin. Endocrinol. Metab.,
January 1, 2007;
92(1):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Shen, L. Zhang, Y. Gan, X. Wang, J. Wang, S. A. LeMaire, J. S. Coselli, and X. L. Wang
Up-regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome Ten) Mediates p38 MAPK Stress Signal-induced Inhibition of Insulin Signaling: A CROSS-TALK BETWEEN STRESS SIGNALING AND INSULIN SIGNALING IN RESISTIN-TREATED HUMAN ENDOTHELIAL CELLS
J. Biol. Chem.,
March 24, 2006;
281(12):
7727 - 7736.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|